Are you interested in hearing more about COVID-19 vaccine safety? Or need more information to support your patients in making decisions? Perhaps friends, family or colleagues are asking questions or you are still unsure and want more information?

Watch the video of this webinar to:

  • learn about the US experience of COVID-19 vaccine safety monitoring and assessment of benefits compared with risks
  • hear about the latest COVID-19 vaccine safety data for children, adolescents and young adults
  • get an update on thrombosis with thrombocytopenia syndrome (TTS) following Vaxzevria (AstraZeneca) COVID-19 vaccine and myocarditis and pericarditis after mRNA COVID-19 vaccination
  • consider the risks and benefits of COVID-19 vaccination and learn strategies for discussions with your patients, friends and family.


Portrait of Dr Tom ShimabukuroDr Tom Shimabukuro
Vaccine Safety Team Lead, COVID-19 Vaccine Task Force
Centers for Disease Control and Prevention (CDC)

Dr Tom Shimabukuro is the deputy director of the Immunization Safety Office at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. He is currently serving as team lead for the Vaccine Safety Team in CDC’s COVID-19 Vaccine Task Force. Dr Shimabukuro received his MD degree from New York University School of Medicine. He did his internship at Emory University School of Medicine and preventive medicine residency at the Johns Hopkins Bloomberg School of Public Health. Dr Shimabukuro also completed a fellowship as an epidemic intelligence service officer at CDC.

Portrait of Associate Professor Nicholas WoodAssociate Professor Nicholas Wood
Associate Director, Clinical Research and Services, NCIRS
Senior Staff Specialist

Nicholas Wood is a staff specialist general paediatrician at the Children’s Hospital at Westmead (CHW) and Associate Professor in the Discipline of Child and Adolescent Health at the University of Sydney. Nick holds an NHMRC Career Development Fellowship. He leads the NSW Immunisation Specialist Service and coordinates the Immunisation Adverse Events Clinic at CHW. He is a senior investigator on the Primary Health Network Immunisation Support Program. Nick is interested in maternal and neonatal immunisation, as well as research into vaccine safety, including genetics and long-term outcomes of adverse events following immunisation.

Portrait of Associate Professor Margie DanchinAssociate Professor Margie Danchin
Group Leader, Vaccine acceptance, Uptake and Policy
Murdoch Children's Research Institute (MCRI)

Margie is a consultant paediatrician at the Royal Children’s Hospital and Clinician Scientist, University of Melbourne, and Murdoch Children’s Research Institute (MCRI). As leader of the vaccine uptake group, MCRI, her research focuses on vaccine confidence and uptake, particularly among high-risk groups and in low- and middle-income countries, and on effective risk communication. In Australia, she is the chair of the Collaboration on Social Science in Immunisation (COSSI) Group, chair of the Social Science Advisory Board and a member of the Scientific Advisory Committee, NCIRS, and on the COVID-19 ATAGI working group. She is on the steering committee of the Australian Regional Immunisation Alliance (ARIA) and the Australian Expert Technical Assistance Program for Regional COVID-19 Vaccine Access: Policy, Planning and Implementation (AETAP-PPI) Advisory Board, and is committed to efforts to improve vaccine confidence and uptake in the Western Pacific Region and globally.  



Last updated October 2021